Let’s take another winding path and down a rabbit hole:
And the clue has been given to us years before, in the name of the progenitor of ModeRNA Inc. - “a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics”.
As we’ve been told by Dr. David E. Martin:
The project that gave rise to the Moderna company itself [Darwinian Chemical Systems] was a project where they were specifically figuring out how to get mRNA to write itself into the genome of the whatever target they were going after ... And the fact of the matter is: Moderna was started on the back of having proven that mRNA can be transfected and write itself into the human genome.
April 2020, Anthony Fauci sat in the President’s Oval Office and talked about how Moderna was going to be the mysterious savior of the world, despite the fact that Moderna had never produced a safe commercial product in its entire operating history.
What you don’t remember is that in 2010, it was the 10th anniversary of the funding that actually started Moderna. You don’t know what the funding that started Moderna is because nobody talks about it. The funding that started Moderna was the National Science Foundation grant called ‘Darwinian Chemical Systems’. https://psuvanguard.com/chemistry-grant-takes-aim-at-lifes-origins/
Darwinian Chemical Systems: In a post-extinction event we want to see if we can mRNA to write into DNA the code to start human evolution again. That’s the 10-year grant that started Moderna.
Darwinian Chemical Systems was to use RNA to write into the DNA of life. The 20-year funding record of the company that’s actually doing it proved that this is what happened.
A post-extinction event? mRNA to write into DNA the code? To start human evolution again?As a task for a 10-year grant from the US government? Maybe as a plot for a science-fiction novel, but the actual research goal? This had stretched my credulity the first time I read about it, on the unconscious level. What got me thinking again about this and the “Darwinian Chemical Systems” was rewatching and re-reading recently this Bourla interview about how Pfizer got pulled into this mRNA “vaccine” business:
mRNA was a technology, but we had less experience, only two years working on this, and actually, mRNA was a technology that never delivered a single product until that day, not vaccine, not any other medicine. So it was very counterintuitive, and I was surprised when they suggested to me that this is the way to go, and I questioned it. And I asked them to justify how can you say something like that, but they came, and they were very, very convinced that this is the right way to go.
They felt that the two years of work on mRNA since 2018 together with BioNTech to develop the flu vaccine made them believe that the technology is mature and we are at the cusp of delivering a product.
So they convinced me. I followed my instinct that they know what they are saying. They are very good, and we made this very difficult decision at that time.
The mRNA specialists at BioNTech have added another deep-pocket pharma giant to the fold. Pfizer has stepped up with a $120 million cash commitment — covering an an uncertain mix of upfront cash, equity and near-term research support — to get the German biotech to focus its drug platform on seasonal and pandemic flu. And there’s another $305 million on the line in potential milestone payouts if they can score marketable products.
So, Bourla dolls out potentially north of 400 million to BioNTech in the middle of 2018 and then is totally oblivious to what was going on over there for two years? Or are “them” some different “them”, bringing some tangible assets and an offer you can’t refuse to the table, under that auspices of the WARP Speed operation? All the know-how, the spike sequences, and the whole mRNA vaccine being patented (World patent WO2021159040A2 - “Sars-cov-2 mrna domain vaccines”) and an intellectual property of Moderna? Sounds very much like Bourla is washing his hands of this decision.
The collaboration has rapidly advanced multiple COVID-19 vaccine candidates into human clinical testing based on BioNTech's proprietary mRNA vaccine platforms, with the objective of ensuring rapid worldwide access to the vaccine, if approved. The collaboration leverages Pfizer's broad expertise in vaccine research and development, regulatory capabilities, and global manufacturing and distribution network. The two companies are jointly conducting clinical trials, and will also work jointly to commercialize the vaccine upon regulatory approval.
I remember reading about Moderna “donating” the S spike recipe to BioNTech for the purpose of vaccine production, that’s why both Moderna and BioNTech jabs are identical in their active mRNA part. If you have the links, please share them in the comments so I can include them here. So, it’s exclusively Moderna’s mRNA code, for all practical purposes. This hasn’t prevented ModeRNA from suing Pfizer/BioNTech duo for the infringement on their mRNA “vaccine” technology in 2022 (“Moderna files patent infringement lawsuits against Pfizer and BioNTech over mRNA Covid-19 vaccines”, CNN Health, 2022.08.26), unless it’s the part of a kabuki show being played out in front of us.
As I described in my post from Nov. 25, 2021, “Addendum to "You Will Know Them by Their Fruits"”, NIH grabbed all S spike and Coronavirus patents and then shared them exclusively with Moderna back in 2019:
2015-11-09: the cooperation in developing mRNA vaccines starts between NIH and Moderna with "Confidential Disclosure Agreement 2015-33448" (https://www.citizen.org/article/the-nih-vaccine/#_ftn2) “The Confidential Information disclosed under this Agreement is described as: For NIAID: NIAID's proprietary information and data relating to the development of vaccines for HIV, influenza, Ebola and MERS and development of broadly neutralizing monoclonal antibodies for preventative and therapeutic use. For Collaborator: Moderna's proprietary and confidential information related to design and manufacture of a messenger RNA platform and messenger RNA constructs for treatment and prevention of disease.”
Jan. 2019: many NIH vaccine patents related to the coronavirus vaccine were allowed to lapse, except NIH forced UNC Chapel Hill to sign the patent for S1 spike protein patent back to NIH (transferred the rights to the real bioweapon to NIH). CDC's patent on coronavirus that they’ve gotten in Apr. 25, 2003 was allowed to lapse in 2018 (they failed to pay the maintenance fee).
May 2019: NIH and Moderna entered into a “research collaboration agreement” to develop vaccine candidates against Middle East Respiratory Syndrome coronavirus (MERS-CoV) and Nipah virus.
This process culminated in NIH’s NIAID and Moderna passing back the fruits of their labour back to Ralph Baric for final testing:
Dec. 12, 2019: Material Transfer agreement "of the mRNA Coronavirus vaccine candidates developed and jointly-owned by NIAID and Moderna to The University of North Carolina at Chapel Hill" for "Perform challenge studies with the mRNA vaccine in a <proprietary info: mammalian?> model as described on Exhibit A". Signed by Ralph Baric.
As well, Moderna has been the company that patented the replacement of uridine residue in the mRNA with m1Ψ (N1-methylpseudouridine) back in 2013, as I have described in “Does mRNA in Jabs Really Produce S Spike from SARS-CoV-2?” from Nov. 27, 2021:
As it turns out, the mRNA instructions to build the "S spike" are far from the ones that should have been used if one truly wished to precisely program for SARS-CoV-2 spikes. For starters, in the Pfizer and Moderna mRNA jabs, every uridine residue in the mRNA is replaced with m1Ψ (N1-methylpseudouridine), which enhances immune evasion of mRNA once inside the cell so that this foreign mRNA is not degraded by the immune system, and thus the protein production is boosted compared to the unmodified mRNA. Coincidentally, this trick has been discovered and patented by Moderna itself in 2013, after a way to enzymatically replace uridine with m1Ψ has been discovered in 2012 (“Identification of the enzyme responsible for N1-methylation of pseudouridine 54 in archaeal tRNAs“). Also, appending a poly A tail to the mRNA, as done by Moderna and Pfizer, can increase its functional life up to tenfold (“Half-Life of mRNA”).
We clearly see almost all of the technologies and intellectual property to produce Covid mRNA “vaccines” has been concentrated, as if by design, in NIAID and Moderna’s hands in 2019.
The rest is history. The governments all around the world coalesced around their medical boards and concluded that there are no Covid treatments available, hence the Covid S spike vaccines is the only way out of the deadly pandemic, the atrocious hospital treatment protocols added the befitting background to the “urgent” situation, and soon it was announced to the masses that “no one will be safe until everyone is jabbed”. Then the “vaccines” failed spectacularly in preventing the virus spread and mutations, and the mRNA boosters became the only way to continue, to feed more spread and mutations, as Geert Vanden Bossche describes so articulately in this recent interview:
And then is where is dawned on me. What if the Darwinian Chemical Systems have been meant not so much for the accelerated Darwinian evolution of the humans but of the virus? According to GVB, this is exactly what’s happening. And while the human reproductive turnaround is 20-30 years, the virus replicates in mere minutes?
As it turns out, the original Darwinian systems branch of knowledge has been concerned with exactly that aspect of evolution:
Darwin's greatest contribution to science is that he completed the Copernican Revolution by drawing out for biology the notion of nature as a system of matter in motion governed by natural laws. With Darwin's discovery of natural selection, the origin and adaptations of organisms were brought into the realm of science. The adaptive features of organisms could now be explained, like the phenomena of the inanimate world, as the result of natural processes, without recourse to an Intelligent Designer.
The theory of evolution conveys chance and necessity jointly enmeshed in the stuff of life; randomness and determinism interlocked in a natural process that has spurted the most complex, diverse, and beautiful entities that we know of in the universe…
The ability to evolve is a key characteristic that distinguishes living things from non-living chemical compounds. The construction of an evolvable cell-like system entirely from non-living molecules has been a major challenge. Here we construct an evolvable artificial cell model from an assembly of biochemical molecules. The artificial cell model contains artificial genomic RNA that replicates through the translation of its encoded RNA replicase. We perform a long-term (600-generation) replication experiment using this system, in which mutations are spontaneously introduced into the RNA by replication error, and highly replicable mutants dominate the population according to Darwinian principles. During evolution, the genomic RNA gradually reinforces its interaction with the translated replicase, thereby acquiring competitiveness against selfish (parasitic) RNAs. This study provides the first experimental evidence that replicating systems can be developed through Darwinian evolution in a cell-like compartment, even in the presence of parasitic replicators.
With rare exceptions, natural evolution is an extremely slow process. One particularly striking exception in the case of protein evolution is in the natural production of antibodies. Developing B cells activate and diversify their immunoglobulin (Ig) genes by recombination, gene conversion (GC) and somatic hypermutation (SHM). Iterative cycles of hypermutation and selection continue until antibodies of high antigen binding specificity emerge (affinity maturation). The avian B cell line DT40, a cell line which is highly amenable to genetic manipulation and exhibits a high rate of targeted integration, utilizes both GC and SHM. Targeting the DT40's diversification machinery onto transgenes of interest inserted into the Ig loci and coupling selective pressure based on the desired outcome mimics evolution. Here we further demonstrate the usefulness of this platform technology by selectively pressuring a large shift in the spectral properties of the fluorescent protein eqFP615 into the highly stable and advanced optical imaging expediting fluorescent protein Amrose. The method is advantageous as it is time and cost effective and no prior knowledge of the outcome protein's structure is necessary. Amrose was evolved to have high excitation at 633 nm and excitation/emission into the far-red, which is optimal for whole-body and deep tissue imaging as we demonstrate in the zebrafish and mouse model.
Development of the Amrose variants
Our strategy was to create a self-directed system which is able to deliver novel mutations without prior knowledge of where these mutations need to occur. Darwinian systems unite these advantages, as they keep a steady, ongoing evolution and “survival” is based on the selection of mutations benefiting, including not harming, the desired trait. DT40 has with 1.3×10−5 mutations/bp/generation [14] a high and stable mutation rate at the immunoglobulin light chain locus, guaranteeing constant diversification of any gene cloned into this region.
Therefore, it has been experimentally proven that it is possible to achieve desired results quite fast, genetic mutations wise, in the biological environments subjected to sufficient Darwinian system pressures.
So, here steps in our Covid-vaccinated global population counting roughly 6 billon, breeding endlessly Covid virus variants, evolutionary-pressured by the the repeated non-neutralizing mRNA vaccinations grounding and limiting the human immune system response. What better way to prove themselves godlike to the godless Illuminati, while fulfilling the hundred-year-old dream of eugenicists, Charles Darwin’s progeny being one of the movement’s founders, of cutting down the human population numbers to manageable levels?
As it has turned out, the mRNA jabs design the milieu, not the product, of this grand experiment. The product will design itself, as it has been doing busily for 3 years now, in the form of a virus variant that will wipe out the milieu participants, if we are to believe GVB. Was it the actual purpose of the original “Darwinian Chemical Systems” grant? I’d love to see the final report, hopefully it’s not classified?
I was surprised when they suggested to me that this is the way to go, and I questioned it. And I asked them to justify how can you say something like that, but they came, and they were very, very convinced that this is the right way to go.
This is not quite correct:
I was surprised when they informed me that this is the way to go, and I questioned it. And I asked them to justify how can you say something like that, but they came, and they were very, very insistent that this is the right way to go and informed me that if I refused to follow their orders they would put a bullet in my head then feed my family to a pack of wolves. So of course... I did what I was told
What a brilliant article. Putting this together was a major effort, but the effort was well worth it. Thank you.
You are the new Igor... this is great stuff...
I was surprised when they suggested to me that this is the way to go, and I questioned it. And I asked them to justify how can you say something like that, but they came, and they were very, very convinced that this is the right way to go.
This is not quite correct:
I was surprised when they informed me that this is the way to go, and I questioned it. And I asked them to justify how can you say something like that, but they came, and they were very, very insistent that this is the right way to go and informed me that if I refused to follow their orders they would put a bullet in my head then feed my family to a pack of wolves. So of course... I did what I was told